{"disease":{"id":"becotatug-vedotin","name":"becotatug vedotin"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07531979","title":"Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":93,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}